Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, according to the New England Journal of Medicine.

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can significantly improve—and in some cases even reverse—advanced liver disease. The findings come from the ESSENCE Phase III clinical trial,

The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated Steatohepatitis (MASH), a serious form of fatty liver disease